The global pharmaceutical gases market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for pharmaceutical gases in hospitals and clinics, home healthcare, universities/research institutions, and pharmaceutical & biotechnology industries. The increasing number of patients suffering from chronic diseases such as asthma and COPD are driving the demand for these gases in hospitals and clinics. Moreover, the growing number of patients with respiratory disorders such as asthma and COPD are also driving the demand for these gases in home healthcare settings. Universities/research institutions are also using these gases extensively due to their use in research laboratories where they are used as a carrier gas or an inert gas that does not react with other chemicals or reactants present in laboratory experiments. Pharmaceutical & biotechnology industries have been using these gases extensively due to their use as solvents or carriers for chemical reactions that produce drugs or other products like plastics etc, which require inert conditions during production process.
- The global pharmaceutical gases market is expected to grow at a CAGR of 4.5% from 2017 to 2022.
- The growth of the global pharmaceutical gases market is driven by factors such as increasing demand for inhalation therapy and growing awareness about the benefits of inhalation therapy in respiratory diseases such as asthma and COPD among patients and physicians.
- Increasing prevalence of respiratory diseases such as asthma and COPD is also driving the growth of the global pharmaceutical gases market due to increased demand for inhalation therapy which can be used in these conditions for better treatment outcomes with minimal side effects compared with other treatments like oral medications or steroids injections which have more side effects associated with them than inhalation therapies do.
- Increasing number of patents on drugs that are used in respiratory diseases such as asthma and COPD are also driving the growth of this market because they provide an opportunity for companies to develop new products that can be patented, thereby providing them with an edge over their competitors who may not have any patent protection on their products or may not have developed any new product yet that can be patented in this area.
Industry Growth Insights published a new data on “Pharmaceutical Gases Market”. The research report is titled “Pharmaceutical Gases Market research by Types (Pharmaceutical Oxygen, Pharmaceutical Nitrous Oxide, Pharmaceutical Air, Pharmaceutical Helium, Others (Medical Nitrogen and Carbon Dioxide etc.)), By Applications (Hospitals (Labs & Clinics), Home Healthcare, Universities/Research Institutions, Pharmaceutical & Biotechnology Industries), By Players/Companies Air Liquide (acquired Airgas in 2016), Linde Healthcare (BOC Healthcare), Praxair, Air Products, Taiyo Nippon Sanso Corporation (Matheson Tri-Gas Inc.), Messer Group, SOL Group, Norco, Air Water Inc, Shenzhen Gaofa”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Gases Market Research Report
By Type
Pharmaceutical Oxygen, Pharmaceutical Nitrous Oxide, Pharmaceutical Air, Pharmaceutical Helium, Others (Medical Nitrogen and Carbon Dioxide etc.)
By Application
Hospitals (Labs & Clinics), Home Healthcare, Universities/Research Institutions, Pharmaceutical & Biotechnology Industries
By Companies
Air Liquide (acquired Airgas in 2016), Linde Healthcare (BOC Healthcare), Praxair, Air Products, Taiyo Nippon Sanso Corporation (Matheson Tri-Gas Inc.), Messer Group, SOL Group, Norco, Air Water Inc, Shenzhen Gaofa
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Gases Market Report Segments:
The global Pharmaceutical Gases market is segmented on the basis of:
Types
Pharmaceutical Oxygen, Pharmaceutical Nitrous Oxide, Pharmaceutical Air, Pharmaceutical Helium, Others (Medical Nitrogen and Carbon Dioxide etc.)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals (Labs & Clinics), Home Healthcare, Universities/Research Institutions, Pharmaceutical & Biotechnology Industries
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Air Liquide (acquired Airgas in 2016)
- Linde Healthcare (BOC Healthcare)
- Praxair
- Air Products
- Taiyo Nippon Sanso Corporation (Matheson Tri-Gas Inc.)
- Messer Group
- SOL Group
- Norco
- Air Water Inc
- Shenzhen Gaofa
Highlights of The Pharmaceutical Gases Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceutical Oxygen
- Pharmaceutical Nitrous Oxide
- Pharmaceutical Air
- Pharmaceutical Helium
- Others (Medical Nitrogen and Carbon Dioxide etc.)
- By Application:
- Hospitals (Labs & Clinics)
- Home Healthcare
- Universities/Research Institutions
- Pharmaceutical & Biotechnology Industries
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Gases Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical gases are a class of gases used in pharmaceuticals and medical devices. They are composed of either nitrogen, oxygen, or argon.
Some of the major companies in the pharmaceutical gases market are Air Liquide (acquired Airgas in 2016), Linde Healthcare (BOC Healthcare), Praxair, Air Products, Taiyo Nippon Sanso Corporation (Matheson Tri-Gas Inc.), Messer Group, SOL Group, Norco, Air Water Inc, Shenzhen Gaofa.
The pharmaceutical gases market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Gases Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Gases Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Gases Market - Supply Chain
4.5. Global Pharmaceutical Gases Market Forecast
4.5.1. Pharmaceutical Gases Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Gases Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Gases Market Absolute $ Opportunity
5. Global Pharmaceutical Gases Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Gases Market Size and Volume Forecast by Type
5.3.1. Pharmaceutical Oxygen
5.3.2. Pharmaceutical Nitrous Oxide
5.3.3. Pharmaceutical Air
5.3.4. Pharmaceutical Helium
5.3.5. Others (Medical Nitrogen and Carbon Dioxide etc.)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Gases Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Gases Market Size and Volume Forecast by Application
6.3.1. Hospitals (Labs & Clinics)
6.3.2. Home Healthcare
6.3.3. Universities/Research Institutions
6.3.4. Pharmaceutical & Biotechnology Industries
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Gases Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Gases Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Gases Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Gases Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Gases Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Gases Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Gases Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Gases Market Size and Volume Forecast by Application
9.4.1. Hospitals (Labs & Clinics)
9.4.2. Home Healthcare
9.4.3. Universities/Research Institutions
9.4.4. Pharmaceutical & Biotechnology Industries
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Gases Market Size and Volume Forecast by Type
9.7.1. Pharmaceutical Oxygen
9.7.2. Pharmaceutical Nitrous Oxide
9.7.3. Pharmaceutical Air
9.7.4. Pharmaceutical Helium
9.7.5. Others (Medical Nitrogen and Carbon Dioxide etc.)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Gases Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Gases Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Gases Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Gases Market Size and Volume Forecast by Application
10.4.1. Hospitals (Labs & Clinics)
10.4.2. Home Healthcare
10.4.3. Universities/Research Institutions
10.4.4. Pharmaceutical & Biotechnology Industries
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Gases Market Size and Volume Forecast by Type
10.7.1. Pharmaceutical Oxygen
10.7.2. Pharmaceutical Nitrous Oxide
10.7.3. Pharmaceutical Air
10.7.4. Pharmaceutical Helium
10.7.5. Others (Medical Nitrogen and Carbon Dioxide etc.)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Gases Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Gases Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Gases Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Gases Market Size and Volume Forecast by Application
11.4.1. Hospitals (Labs & Clinics)
11.4.2. Home Healthcare
11.4.3. Universities/Research Institutions
11.4.4. Pharmaceutical & Biotechnology Industries
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Gases Market Size and Volume Forecast by Type
11.7.1. Pharmaceutical Oxygen
11.7.2. Pharmaceutical Nitrous Oxide
11.7.3. Pharmaceutical Air
11.7.4. Pharmaceutical Helium
11.7.5. Others (Medical Nitrogen and Carbon Dioxide etc.)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Gases Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Gases Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Gases Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Gases Market Size and Volume Forecast by Application
12.4.1. Hospitals (Labs & Clinics)
12.4.2. Home Healthcare
12.4.3. Universities/Research Institutions
12.4.4. Pharmaceutical & Biotechnology Industries
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Gases Market Size and Volume Forecast by Type
12.7.1. Pharmaceutical Oxygen
12.7.2. Pharmaceutical Nitrous Oxide
12.7.3. Pharmaceutical Air
12.7.4. Pharmaceutical Helium
12.7.5. Others (Medical Nitrogen and Carbon Dioxide etc.)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Gases Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Gases Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Gases Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Gases Market Size and Volume Forecast by Application
13.4.1. Hospitals (Labs & Clinics)
13.4.2. Home Healthcare
13.4.3. Universities/Research Institutions
13.4.4. Pharmaceutical & Biotechnology Industries
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Gases Market Size and Volume Forecast by Type
13.7.1. Pharmaceutical Oxygen
13.7.2. Pharmaceutical Nitrous Oxide
13.7.3. Pharmaceutical Air
13.7.4. Pharmaceutical Helium
13.7.5. Others (Medical Nitrogen and Carbon Dioxide etc.)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Gases Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Gases Market: Market Share Analysis
14.2. Pharmaceutical Gases Distributors and Customers
14.3. Pharmaceutical Gases Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Air Liquide (acquired Airgas in 2016)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Linde Healthcare (BOC Healthcare)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Praxair
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Air Products
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Taiyo Nippon Sanso Corporation (Matheson Tri-Gas Inc.)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Messer Group
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. SOL Group
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Norco
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Air Water Inc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Shenzhen Gaofa
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
